circACTG1 Promotes Hepatocellular Carcinoma Progression by Regulating miR-940/RIF1 Axis and Activating AKT/mTOR Pathway

Figure 5

The AKT-mTOR pathway was activated by circACTG1/miR-940/RIF1 axis. (a and b) Expression of RIF1 after transfecting miR-940 mimic. (c and d) Expression of RIF1 after transfecting shcircACTG1. (e and f) Expression of RIF1 with circACTG1 knockdown or combined with miR-940 inhibitor. (g) Overall survival of RIF1 expression. (h–j) AKT-mTOR pathway molecule expression after transfecting miR940 mimic (h), shcircACTG1 (i), and shcircACTG1 and miR-940 inhibitor (j).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)